Monday, September 10, 2012
Eaton Scientific Systems Ltd., of Beverly Hills, Calif., a wholly owned subsidiary of Pristine Solutions Inc., said it completed the protocol for the Phase I/II study of Tropine 3, its version of homatropine in oral suspension, for women afflicted with hot flashes during pre-menopause, perimenopause and postmenopause.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.